The role of dendritic cell precursors in tumour vasculogenesis: Minireview

In this review, we discuss the recent identification in vivo of a population of CD11c + cells exhibiting simultaneous expression of both endothelial and dendritic cell markers, termed vascular leukocytes (VLCs). VLCs are highly represented in human ovarian carcinomas and, depending on the milieu, ca...

Full description

Saved in:
Bibliographic Details
Published in:British journal of cancer 2005-04, Vol.92 (7), p.1182-1187
Main Authors: Coukos, G, Benencia, F, Buckanovich, R J, Conejo-Garcia, J R
Format: Article
Language:English
Subjects:
Biomedical and Life Sciences
Biomedicine
Cancer Research
Drug Resistance
Epidemiology
mini-review
Molecular Medicine
Oncology
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 1187
container_issue 7
container_start_page 1182
container_title British journal of cancer
container_volume 92
creator Coukos, G
Benencia, F
Buckanovich, R J
Conejo-Garcia, J R
description In this review, we discuss the recent identification in vivo of a population of CD11c + cells exhibiting simultaneous expression of both endothelial and dendritic cell markers, termed vascular leukocytes (VLCs). VLCs are highly represented in human ovarian carcinomas and, depending on the milieu, can assemble into functional blood vessels or act as antigen-presenting cells. The identification of dendritic cell precursors as bipotent cells has important implications for the physiopathology and therapy of tumours. VLCs emerge as a novel therapeutic target against tumour vascularisation.
doi_str_mv 10.1038/sj.bjc.6602476
format article
fullrecord <record><control><sourceid>springer</sourceid><recordid>TN_cdi_springer_journals_10_1038_sj_bjc_6602476</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1038_sj_bjc_6602476</sourcerecordid><originalsourceid>FETCH-springer_journals_10_1038_sj_bjc_66024763</originalsourceid><addsrcrecordid>eNqVjksKwjAURYMoWD9Tx9lA25dU2zpxIooLcB5qfNaEmJQ86_qt0A04uhwuBw5jGwGZgKLOyWY3q7OyBLmtyglLxK6QqahlNWUJAFQp7CXM2YLIDriHukrY4fpEHoNDHh78jv4ezdtortE53kXUfaQQiRvP3_0r9JF_GtK9Cy16JEMrNns0jnA97pLl59P1eEmpi8a3GJUdJD9cSoD6ZSqyashUY2bxv_EFrg5How</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The role of dendritic cell precursors in tumour vasculogenesis: Minireview</title><source>PubMed Central</source><creator>Coukos, G ; Benencia, F ; Buckanovich, R J ; Conejo-Garcia, J R</creator><creatorcontrib>Coukos, G ; Benencia, F ; Buckanovich, R J ; Conejo-Garcia, J R</creatorcontrib><description>In this review, we discuss the recent identification in vivo of a population of CD11c + cells exhibiting simultaneous expression of both endothelial and dendritic cell markers, termed vascular leukocytes (VLCs). VLCs are highly represented in human ovarian carcinomas and, depending on the milieu, can assemble into functional blood vessels or act as antigen-presenting cells. The identification of dendritic cell precursors as bipotent cells has important implications for the physiopathology and therapy of tumours. VLCs emerge as a novel therapeutic target against tumour vascularisation.</description><identifier>ISSN: 0007-0920</identifier><identifier>EISSN: 1532-1827</identifier><identifier>DOI: 10.1038/sj.bjc.6602476</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>Biomedical and Life Sciences ; Biomedicine ; Cancer Research ; Drug Resistance ; Epidemiology ; mini-review ; Molecular Medicine ; Oncology</subject><ispartof>British journal of cancer, 2005-04, Vol.92 (7), p.1182-1187</ispartof><rights>The Author(s) 2005</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Coukos, G</creatorcontrib><creatorcontrib>Benencia, F</creatorcontrib><creatorcontrib>Buckanovich, R J</creatorcontrib><creatorcontrib>Conejo-Garcia, J R</creatorcontrib><title>The role of dendritic cell precursors in tumour vasculogenesis: Minireview</title><title>British journal of cancer</title><addtitle>Br J Cancer</addtitle><description>In this review, we discuss the recent identification in vivo of a population of CD11c + cells exhibiting simultaneous expression of both endothelial and dendritic cell markers, termed vascular leukocytes (VLCs). VLCs are highly represented in human ovarian carcinomas and, depending on the milieu, can assemble into functional blood vessels or act as antigen-presenting cells. The identification of dendritic cell precursors as bipotent cells has important implications for the physiopathology and therapy of tumours. VLCs emerge as a novel therapeutic target against tumour vascularisation.</description><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cancer Research</subject><subject>Drug Resistance</subject><subject>Epidemiology</subject><subject>mini-review</subject><subject>Molecular Medicine</subject><subject>Oncology</subject><issn>0007-0920</issn><issn>1532-1827</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNqVjksKwjAURYMoWD9Tx9lA25dU2zpxIooLcB5qfNaEmJQ86_qt0A04uhwuBw5jGwGZgKLOyWY3q7OyBLmtyglLxK6QqahlNWUJAFQp7CXM2YLIDriHukrY4fpEHoNDHh78jv4ezdtortE53kXUfaQQiRvP3_0r9JF_GtK9Cy16JEMrNns0jnA97pLl59P1eEmpi8a3GJUdJD9cSoD6ZSqyashUY2bxv_EFrg5How</recordid><startdate>20050411</startdate><enddate>20050411</enddate><creator>Coukos, G</creator><creator>Benencia, F</creator><creator>Buckanovich, R J</creator><creator>Conejo-Garcia, J R</creator><general>Nature Publishing Group UK</general><scope>C6C</scope></search><sort><creationdate>20050411</creationdate><title>The role of dendritic cell precursors in tumour vasculogenesis</title><author>Coukos, G ; Benencia, F ; Buckanovich, R J ; Conejo-Garcia, J R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-springer_journals_10_1038_sj_bjc_66024763</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cancer Research</topic><topic>Drug Resistance</topic><topic>Epidemiology</topic><topic>mini-review</topic><topic>Molecular Medicine</topic><topic>Oncology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Coukos, G</creatorcontrib><creatorcontrib>Benencia, F</creatorcontrib><creatorcontrib>Buckanovich, R J</creatorcontrib><creatorcontrib>Conejo-Garcia, J R</creatorcontrib><collection>Springer Nature OA Free Journals</collection><jtitle>British journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Coukos, G</au><au>Benencia, F</au><au>Buckanovich, R J</au><au>Conejo-Garcia, J R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The role of dendritic cell precursors in tumour vasculogenesis: Minireview</atitle><jtitle>British journal of cancer</jtitle><stitle>Br J Cancer</stitle><date>2005-04-11</date><risdate>2005</risdate><volume>92</volume><issue>7</issue><spage>1182</spage><epage>1187</epage><pages>1182-1187</pages><issn>0007-0920</issn><eissn>1532-1827</eissn><abstract>In this review, we discuss the recent identification in vivo of a population of CD11c + cells exhibiting simultaneous expression of both endothelial and dendritic cell markers, termed vascular leukocytes (VLCs). VLCs are highly represented in human ovarian carcinomas and, depending on the milieu, can assemble into functional blood vessels or act as antigen-presenting cells. The identification of dendritic cell precursors as bipotent cells has important implications for the physiopathology and therapy of tumours. VLCs emerge as a novel therapeutic target against tumour vascularisation.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><doi>10.1038/sj.bjc.6602476</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-0920
ispartof British journal of cancer, 2005-04, Vol.92 (7), p.1182-1187
issn 0007-0920
1532-1827
language eng
recordid cdi_springer_journals_10_1038_sj_bjc_6602476
source PubMed Central
subjects Biomedical and Life Sciences
Biomedicine
Cancer Research
Drug Resistance
Epidemiology
mini-review
Molecular Medicine
Oncology
title The role of dendritic cell precursors in tumour vasculogenesis: Minireview
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T16%3A09%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-springer&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20role%20of%20dendritic%20cell%20precursors%20in%20tumour%20vasculogenesis:%20Minireview&rft.jtitle=British%20journal%20of%20cancer&rft.au=Coukos,%20G&rft.date=2005-04-11&rft.volume=92&rft.issue=7&rft.spage=1182&rft.epage=1187&rft.pages=1182-1187&rft.issn=0007-0920&rft.eissn=1532-1827&rft_id=info:doi/10.1038/sj.bjc.6602476&rft_dat=%3Cspringer%3E10_1038_sj_bjc_6602476%3C/springer%3E%3Cgrp_id%3Ecdi_FETCH-springer_journals_10_1038_sj_bjc_66024763%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true